CYTOTOOLS Financials
| T5O Stock | 0.47 0.07 12.96% |
CYTOTOOLS |
Understanding current and past CYTOTOOLS Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CYTOTOOLS's financial statements are interrelated, with each one affecting the others. For example, an increase in CYTOTOOLS's assets may result in an increase in income on the income statement.
The data published in CYTOTOOLS's official financial statements typically reflect CYTOTOOLS's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving CYTOTOOLS's quantitative information. For example, before you start analyzing numbers published by CYTOTOOLS accountants, it’s essential to understand CYTOTOOLS's liquidity, profitability, and earnings quality within the context of the Other space in which it operates.
Please note, the imprecision that can be found in CYTOTOOLS's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CYTOTOOLS. Check CYTOTOOLS's Beneish M Score to see the likelihood of CYTOTOOLS's management manipulating its earnings.
You should never invest in CYTOTOOLS without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of CYTOTOOLS Stock, because this is throwing your money away. Analyzing the key information contained in CYTOTOOLS's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
CYTOTOOLS Key Financial Ratios
CYTOTOOLS's financial ratios allow both analysts and investors to convert raw data from CYTOTOOLS's financial statements into concise, actionable information that can be used to evaluate the performance of CYTOTOOLS over time and compare it to other companies across industries.CYTOTOOLS Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CYTOTOOLS's current stock value. Our valuation model uses many indicators to compare CYTOTOOLS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CYTOTOOLS competition to find correlations between indicators driving CYTOTOOLS's intrinsic value. More Info.CYTOTOOLS is rated below average in current valuation category among its peers. It also is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for CYTOTOOLS is about 19,107,376 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CYTOTOOLS's earnings, one of the primary drivers of an investment's value.CYTOTOOLS Systematic Risk
CYTOTOOLS's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CYTOTOOLS volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on CYTOTOOLS correlated with the market. If Beta is less than 0 CYTOTOOLS generally moves in the opposite direction as compared to the market. If CYTOTOOLS Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CYTOTOOLS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CYTOTOOLS is generally in the same direction as the market. If Beta > 1 CYTOTOOLS moves generally in the same direction as, but more than the movement of the benchmark.
CYTOTOOLS June 7, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CYTOTOOLS help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CYTOTOOLS. We use our internally-developed statistical techniques to arrive at the intrinsic value of CYTOTOOLS based on widely used predictive technical indicators. In general, we focus on analyzing CYTOTOOLS Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CYTOTOOLS's daily price indicators and compare them against related drivers.
| Downside Deviation | 15.5 | |||
| Information Ratio | 0.1037 | |||
| Maximum Drawdown | 73.33 | |||
| Value At Risk | (13.33) | |||
| Potential Upside | 19.23 |
Additional Tools for CYTOTOOLS Stock Analysis
When running CYTOTOOLS's price analysis, check to measure CYTOTOOLS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CYTOTOOLS is operating at the current time. Most of CYTOTOOLS's value examination focuses on studying past and present price action to predict the probability of CYTOTOOLS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CYTOTOOLS's price. Additionally, you may evaluate how the addition of CYTOTOOLS to your portfolios can decrease your overall portfolio volatility.